Literature DB >> 15475242

A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.

Li Yu1, Chunhui Liu, Kristi Bennett, Yue-Zhong Wu, Zunyan Dai, Jeff Vandeusen, Rene Opavsky, Aparna Raval, Prashant Trikha, Ben Rodriguez, Brian Becknell, Charlene Mao, Stephen Lee, Ramana V Davuluri, Gustavo Leone, Ignatia B Van den Veyver, Michael A Caligiuri, Christoph Plass.   

Abstract

Aberrant promoter methylation and associated chromatin changes are primarily studied in human malignancies. Thus far, mouse models for human cancer have been rarely utilized to study the role of DNA methylation in tumor onset and progression. It would be advantageous to use mouse tumor models to a greater extent to study the role and mechanism of DNA methylation in cancer because mouse models allow manipulation of the genome, study of samples/populations with a homogeneous genetic background, the possibility of modulating gene expression in vivo, the statistical power of using large numbers of tumor samples, access to various tumor stages, and the possibility of preclinical trials. Therefore, it is likely that the mouse will emerge as an increasingly utilized model to study DNA methylation in cancer. To foster the use of mouse models, we developed an arrayed mouse NotI-EcoRV genomic library, with clones from three commonly used mouse strains (129SvIMJ, FVB/NJ, and C57BL/6J). A total of 23,040 clones representing an estimated three- to fourfold coverage of the mouse genome were arrayed in 60 x 384-well plates. We developed restriction landmark genomic scanning (RLGS) mixing gels with 32 plates to enable the cloning of methylated sequences from RLGS profiles run with NotI-EcoRV-HinfI. RLGS was used to study aberrant methylation in two mouse models that overexpressed IL-15 or c-Myc and developed either T/NK-cell leukemia or T-cell lymphomas, respectively. Careful analysis of 198 sequences showed that 188 (94.9%) identified CpG-island sequences, 132 sequences (66.7%) had homology to the 5' regions of known genes or mRNAs, and all 132 NotI-EcoRV clones were located at the same CpG islands with the predicted promoter sequences. We have also developed a modified pGL3-based luciferase vector that now contains the NotI, AscI, and EcoRV restriction sites and allows the rapid cloning of NotI-EcoRV library fragments in both orientations. Luciferase assays using NotI-EcoRV clones confirmed that the library is enriched for promoter sequences. Thus, this library will support future genetic and epigenetic studies in mouse models. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475242     DOI: 10.1016/j.ygeno.2004.06.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues.

Authors:  Srimoyee Ghosh; Allan J Yates; Michael C Frühwald; Jeffrey C Miecznikowski; Christoph Plass; Dominic Smiraglia
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

2.  Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.

Authors:  Kristi L Bennett; Jessica Mester; Charis Eng
Journal:  JAMA       Date:  2010-12-22       Impact factor: 56.272

3.  A unique configuration of genome-wide DNA methylation patterns in the testis.

Authors:  C C Oakes; S La Salle; D J Smiraglia; B Robaire; J M Trasler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

4.  cuRRBS: simple and robust evaluation of enzyme combinations for reduced representation approaches.

Authors:  Daniel E Martin-Herranz; António J M Ribeiro; Felix Krueger; Janet M Thornton; Wolf Reik; Thomas M Stubbs
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

5.  Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.

Authors:  Kristi L Bennett; Rebecca Campbell; Shireen Ganapathi; Ming Zhou; Brian Rini; Ram Ganapathi; Hartmut P H Neumann; Charis Eng
Journal:  Genes Chromosomes Cancer       Date:  2011-05-16       Impact factor: 5.006

6.  A novel role for mitochondria in regulating epigenetic modification in the nucleus.

Authors:  Dominic J Smiraglia; Mariola Kulawiec; Gaia L Bistulfi; Sampa Ghoshal Gupta; Keshav K Singh
Journal:  Cancer Biol Ther       Date:  2008-08-01       Impact factor: 4.742

7.  Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.

Authors:  Shannon R Morey Kinney; Dominic J Smiraglia; Smitha R James; Michael T Moser; Barbara A Foster; Adam R Karpf
Journal:  Mol Cancer Res       Date:  2008-07-30       Impact factor: 5.852

8.  TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.

Authors:  Jianhua Yu; Maxim Ershler; Li Yu; Min Wei; Björn Hackanson; Akihiko Yokohama; Takeki Mitsui; Chunhui Liu; Hsiaoyin Mao; Shujun Liu; Zhongfa Liu; Rossana Trotta; Chang-gong Liu; Xiuping Liu; Kun Huang; Jan Visser; Guido Marcucci; Christoph Plass; Alexander V Belyavsky; Michael A Caligiuri
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

9.  Phenotype-specific CpG island methylation events in a murine model of prostate cancer.

Authors:  Marta Camoriano; Shannon R Morey Kinney; Michael T Moser; Barbara A Foster; James L Mohler; Donald L Trump; Adam R Karpf; Dominic J Smiraglia
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells.

Authors:  Gaia Bistulfi; Erika Vandette; Sei-Ichi Matsui; Dominic J Smiraglia
Journal:  BMC Biol       Date:  2010-01-21       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.